Disclosure Logs
- 20/08/2025
- Ovarian cancer
-
-
-
FOI.17783
Ovarian cancer
- 20/08/2025
- Diversity, Equality, and Inclusion (DEI) and LGBTQ+ initiatives
-
-
-
FOI.17844
Diversity, Equality, and Inclusion (DEI) and LGBTQ+ initiatives
- 20/08/2025
- Hospital data
-
-
-
FOI.17716
Hospital data
- 20/08/2025
- Insourcing
-
-
-
FOI.17723
Insourcing
- 20/08/2025
- Telephony System and Contact Centre
-
-
-
FOI.17846
Telephony System and Contact Centre
- 20/08/2025
- Puberty blockers and cross sex hormones
-
-
-
FOI.17775
Puberty blockers and cross sex hormones
- 20/08/2025
- Diagnostic imaging services
-
-
-
FOI.17721
Diagnostic imaging services
- 20/08/2025
- Myelofibrosis treatments
-
-
-
FOI.17718
Myelofibrosis treatments
- 20/08/2025
- Hospital transport
-
-
-
FOI.17713
Hospital transport
- 20/08/2025
- Overseas visitors
-
-
-
FOI.17712
Overseas visitors
- 20/08/2025
- Urothelial cancer
-
-
-
FOI.17821
Urothelial cancer
- 20/08/2025
- Adult Attention Deficit Hyperactivity Disorder (ADHD) Assessments
-
-
-
FOI.17802
Adult Attention Deficit Hyperactivity Disorder (ADHD) Assessments
- 20/08/2025
- Consanguinity
-
-
-
FOI.17807
Consanguinity
- 20/08/2025
- Website News Item and email addresses and correspondence
-
-
-
FOI.17695 & 17707
Website News Item and email addresses and correspondence
- 20/08/2025
- Patient removals from waiting lists
-
-
-
FOI.17694
Patient removals from waiting lists
- 15/08/2025
- Osteoporosis Pathways
-
-
-
FOI.17767
Osteoporosis Pathways
- 15/08/2025
- Neurodevelopmental services for Children and Young People (CYP)
-
-
-
FOI.17755
Neurodevelopmental services for Children and Young People (CYP)
- 15/08/2025
- Policy documents
-
-
-
FOI.17696
Policy documents
- 15/08/2025
- Formaldehyde levels
-
-
-
FOI.17685
Formaldehyde levels
- 15/08/2025
- Public consultations
-
-
-
FOI.17659
Public consultations